Biotech IPOs are definitely back. In addition to recent pricings we have 4 more deals in active marketing and there were 9 new filings in the last 30 days. We've added the recent crop of companies to the roadshow archive. Their descriptions and links are below. Adding up the market capitalizations of just these deals the total new market value is $2.4B.
Biotech Roadshow Archive Additions
Epizyme (EPZM) is a clinical stage biopharmaceutical company working on personalized therapeutics for the treatment of patients with genetically defined cancers. They have strategic . . .

Want the rest of the article?

Please login or join us as a member to view our complete content!